Incyte insider sales
WebApr 11, 2024 · Insider Trading Selling Shares $5.68 M Sold Last Quarter Proj. Earnings Growth 37.99% From $3.29 to $4.54 Per Share See Full Details Overall MarketRank ™ 2.80 … WebMay 3, 2024 · May 3, 2024 at 7:00 AM EDT. PDF Version. Total product and royalty revenues of $728 million in Q1’22 (+20% Y/Y) Jakafi® (ruxolitinib) net product revenues of $544 …
Incyte insider sales
Did you know?
WebWe would like to show you a description here but the site won’t allow us. WebIncyte Corp. 1801 Augustine Cut-Off Wilmington, Delaware 19803 Phone 1 302 498-6700 Industry Biotechnology Sector Health Care/Life Sciences Fiscal Year-end 12/2024 Revenue $2.99B Net Income...
WebFeb 7, 2024 · Incyte Reports 2024 Fourth Quarter and Year-end Financial Results, Provides 2024 Financial Guidance and Updates on Key Clinical Programs February 7, 2024 at 7:00 … WebApr 11, 2024 · On Friday 03/31/2024 the closing price of the Incyte Corp. share was $75.51 on NAS. Compared to the opening price on Friday 03/31/2024 on NAS of $74.10, this is a …
WebApr 15, 2024 · 3.00. Incyte presently has a consensus price target of $85.43, indicating a potential upside of 14.67%. MaxCyte has a consensus price target of $10.50, indicating a potential upside of 96.26% ... WebFind the latest Insider Activity data for Incyte Corp. Common Stock (INCY) at Nasdaq.com.
WebAug 17, 2024 · Washington D.C., Aug. 17, 2024 —. The Securities and Exchange Commission today charged a former employee of California-based Medivation Inc. with insider trading in advance of Medivation's announcement that it would be acquired by pharmaceutical giant Pfizer Inc. According to the SEC's complaint, filed in the U.S. District Court for the ...
WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 … orange and red striped socksWebApr 12, 2024 · Morgan Stanley boosted their price objective on shares of Incyte from $76.00 to $77.00 in a research report on Wednesday. ... Insider Buying and Selling at Incyte. ... The stock was sold at an average price of $84.74, for a total value of $5,086,433.76. Following the sale, the executive vice president now owns 68,524 shares in the company ... orange and rockland bill assistanceWebApr 9, 2024 · Insider Buying and Selling at Incyte In other news, EVP Maria E. Pasquale sold 60,024 shares of Incyte stock in a transaction dated Monday, January 30th. The stock was sold at an average... orange and rockland ev incentivesWebApr 15, 2024 · Insider Activity at Incyte In other Incyte news, EVP Maria E. Pasquale sold 60,024 shares of the firm’s stock in a transaction dated Monday, January 30th. The stock … orange and rockland con edWebApr 10, 2024 · Incyte’s 2024 sales guidance also indicates that “competitive dynamics could start to more meaningfully impact Jakafi’s trajectory,” Abrahams stated. The stock is … iphone 7 front and back camera megapixelsWebGet the latest updated list of insiders for Incyte Corporation (INCY). Find out the total of insider shares held, purchased and sold. orange and roWebApr 13, 2024 · Insider Transactions at Incyte. ... The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Vijay K. Iyengar sold 7,000 shares of Incyte stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average price of $85.00, for a ... orange and rhubarb cake